Business Description
Poolbeg Pharma PLC
ISIN : GB00BKPG7Z60
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.94 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.18 | |||||
9-Day RSI | 45.81 | |||||
14-Day RSI | 44.89 | |||||
6-1 Month Momentum % | 23.3 | |||||
12-1 Month Momentum % | 76.39 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 13.69 | |||||
Quick Ratio | 13.69 | |||||
Cash Ratio | 12.34 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -23.91 | |||||
ROA % | -22.77 | |||||
ROIC % | -142.08 | |||||
ROC (Joel Greenblatt) % | -4733.33 | |||||
ROCE % | -28.5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 3.88 | |||||
Price-to-Tangible-Book | 4.33 | |||||
EV-to-EBIT | -9.03 | |||||
EV-to-Forward-EBIT | -7.47 | |||||
EV-to-EBITDA | -9.08 | |||||
EV-to-Forward-EBITDA | -7.47 | |||||
EV-to-FCF | -9.67 | |||||
Price-to-Net-Current-Asset-Value | 4.33 | |||||
Price-to-Net-Cash | 6.5 | |||||
Earnings Yield (Greenblatt) % | -11.08 | |||||
FCF Yield % | -8.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Poolbeg Pharma PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.009 | ||
Beta | 2.32 | ||
Volatility % | 53.94 | ||
14-Day RSI | 44.89 | ||
14-Day ATR (€) | 0.00252 | ||
20-Day SMA (€) | 0.1335 | ||
12-1 Month Momentum % | 76.39 | ||
52-Week Range (€) | 0.0665 - 0.173 | ||
Shares Outstanding (Mil) | 500 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Poolbeg Pharma PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Poolbeg Pharma PLC Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Poolbeg Pharma PLC Frequently Asked Questions
What is Poolbeg Pharma PLC(STU:7JN)'s stock price today?
When is next earnings date of Poolbeg Pharma PLC(STU:7JN)?
Does Poolbeg Pharma PLC(STU:7JN) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |